Unveiling the Future of Cannabis-Pharmaceutical Collaboration


On May 23, 2024, Business of Cannabis will host the Zurich Executive Summit, bringing together a wide range of leaders from the pharmaceutical and cannabis industries, along with investors and public health policymakers.

The summit will address how the intersection between the cannabis and pharmaceutical industries has been evolving, improving and modernizing, moving closer to their convergence in the near future.

Amid growing interest and investment in medicinal cannabis, the summit will feature the experiences of leading pharmaceutical and cannabis companies, including Linnea, Cannavigia, Brains Biocutical and Dascoli Pharma.

Leading Swiss pharmaceutical manufacturer Linnea, one of the first companies in the world to achieve full GMP accreditation for CBD isolate, will kick off the summit with a presentation on how to develop pharmaceutical-grade cannabinoids.

The international hemp fair CannaTrade will be held from May 24 to 26, also in Zurich. It will host more than 150 exhibitors from around the world, and will address such interesting topics as the pilot projects being carried out in Switzerland, as well as recommendations for cultivation.

CBD for skin anomalies and relieve pain

AZ Pharma Care, through medical research, proposes new answers to combat skin anomalies and relieve pain, through a perfect balance between technology and the benefits provided by cannabidiol and other ingredients present in nature, achieving products that are more natural, effective, and fast.

The AZ Pharma Care range is only prescribed by health professionals, it is only sold in pharmacies and in the official AZ Pharma Care online store.

Productos AZ Pharma Care